Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia
- Author
- SERNYAK, Michael J; LESLIE, Douglas L; ALARCON, Renato D; LOSONCZY, Miklos F; ROSENHECK, Robert
Psychiatry Service, Atlanta VA Medical Center, and Department of Psychiatry, Emory University School of Medicine, Atlanta, United States
Psychiatry Service, VA Connecticut Healthcare System, United States
Psychiatry Service, VA New Jersey Healthcare System, and Department of Psychiatry, University of Medicine and Dentistry of New Jersey, New Jersey Medical School and Robert Wood JohnsonSchool of Medicine, East Orange, N.J, United States
VA Mental Illness Research, Education, and Clinical Center, and Department of Psychiatry, Yale University School of Medicine, New Haven, Conn., United States
VA Northeast Program Evaluation Center, New Haven, Conn., United States - Source
The American journal of psychiatry. 2002, Vol 159, Num 4, pp 561-566 ; ref : 30 ref
- CODEN
- AJPSAO
- ISSN
- 0002-953X
- Scientific domain
- Psychology, psychopathology, psychiatry
- Publisher
- American Psychiatric Association, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Association morbide Atypique Chimiothérapie Diabète Environnement social Etude longitudinale Homme Maladie Neuroleptique Prévalence Psychotrope Santé mentale Santé publique Schizophrénie Toxicité Traitement Typologie Maladie somatique Etats Unis Endocrinopathie Psychose Amérique du Nord Amérique
- Keyword (en)
- Concomitant disease Atypical Chemotherapy Diabetes mellitus Social environment Follow up study Human Disease Neuroleptic Prevalence Psychotropic Mental health Public health Schizophrenia Toxicity Treatment Typology Somatic disease United States Endocrinopathy Psychosis North America America
- Keyword (es)
- Asociación morbosa Atípico Quimioterapia Diabetes Medio ambiente social Estudio longitudinal Hombre Enfermedad Neuroléptico Prevalencia Psicotropo Salud mental Salud pública Esquizofrenia Toxicidad Tratamiento Tipología Estados Unidos Endocrinopatía Psicosis America del norte America
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02U Drug toxicity and drugs side effects treatment / 002B02U10 Miscellaneous (drug allergy, mutagens, teratogens...)
- Discipline
- Drugs toxicity and drug intoxications Toxicology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13628448
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1176/appi.ajp.159.4.561 
https://dx.doi.org/10.1176/appi.ajp.159.4.561
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1176\/appi.ajp.159.4.561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of psychiatry\";s:9:\"\u0000*\u0000stitle\";s:16:\"Am. j. psychiatr\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"159\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"561\";s:8:\"\u0000*\u0000epage\";s:3:\"566\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-953X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SERNYAK\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:17:\"LESLIE, Douglas L\";i:1;s:17:\"ALARCON, Renato D\";i:2;s:18:\"LOSONCZY, Miklos F\";i:3;s:17:\"ROSENHECK, Robert\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJPSAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:32:\"American Psychiatric Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1176\/appi.ajp.159.4.561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of psychiatry\";s:9:\"\u0000*\u0000stitle\";s:16:\"Am. j. psychiatr\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"159\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"561\";s:8:\"\u0000*\u0000epage\";s:3:\"566\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-953X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SERNYAK\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:17:\"LESLIE, Douglas L\";i:1;s:17:\"ALARCON, Renato D\";i:2;s:18:\"LOSONCZY, Miklos F\";i:3;s:17:\"ROSENHECK, Robert\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJPSAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:32:\"American Psychiatric Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1176\/appi.ajp.159.4.561\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1176\/appi.ajp.159.4.561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of psychiatry\";s:9:\"\u0000*\u0000stitle\";s:16:\"Am. j. psychiatr\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"159\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"561\";s:8:\"\u0000*\u0000epage\";s:3:\"566\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-953X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SERNYAK\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:17:\"LESLIE, Douglas L\";i:1;s:17:\"ALARCON, Renato D\";i:2;s:18:\"LOSONCZY, Miklos F\";i:3;s:17:\"ROSENHECK, Robert\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJPSAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:32:\"American Psychiatric Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1176\/appi.ajp.159.4.561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of psychiatry\";s:9:\"\u0000*\u0000stitle\";s:16:\"Am. j. psychiatr\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"159\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"561\";s:8:\"\u0000*\u0000epage\";s:3:\"566\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-953X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SERNYAK\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:17:\"LESLIE, Douglas L\";i:1;s:17:\"ALARCON, Renato D\";i:2;s:18:\"LOSONCZY, Miklos F\";i:3;s:17:\"ROSENHECK, Robert\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJPSAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:32:\"American Psychiatric Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1176\/appi.ajp.159.4.561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of psychiatry\";s:9:\"\u0000*\u0000stitle\";s:16:\"Am. j. psychiatr\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"159\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"561\";s:8:\"\u0000*\u0000epage\";s:3:\"566\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-953X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SERNYAK\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:17:\"LESLIE, Douglas L\";i:1;s:17:\"ALARCON, Renato D\";i:2;s:18:\"LOSONCZY, Miklos F\";i:3;s:17:\"ROSENHECK, Robert\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJPSAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:100:\"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:32:\"American Psychiatric Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
